Synapse

← Adrian L. Harris

Papers by Adrian L. Harris

Page 7 · newest first

  1. Evaluation of the current knowledge limitations in breast cancer research: a gap analysisBreast Cancer Research · 2008
  2. Regulation of CXCR4 by the Notch Ligand Delta-like 4 in Endothelial CellsCancer Research · 2008
  3. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphomaBritish Journal of Haematology · 2008
  4. hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast CancerClinical Cancer Research · 2008
  5. Measuring Angiogenic Cytokines, Circulating Endothelial Cells, and Endothelial Progenitor Cells in Peripheral Blood and Cord Blood: VEGF and CXCL12 Correlate with the Number of Circulating Endothelial Progenitor Cells in Peripheral BloodTissue Engineering Part C Methods · 2008
  6. BHLHB2 Controls Bdnf Promoter 4 Activity and Neuronal ExcitabilityJournal of Neuroscience · 2008
  7. Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteinsLeukemia & lymphoma/Leukemia and lymphoma · 2008
  8. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancerBreast Cancer Research · 2007
  9. Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivoCancer Research · 2007
  10. Breast tumour angiogenesisBreast Cancer Research · 2007
  11. Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancerBritish Journal of Cancer · 2007
  12. Activated Vegfr2/kdr Pathway In Tumour Cells And Tumour Associated Vessels Of Colorectal CancerEuropean Journal of Clinical Investigation · 2007
  13. Mobilization of endothelial progenitor cells into the circulation in burned patientsBritish journal of surgery · 2007
  14. Systematic Review of Multiple Studies of Prognosis: The Feasibility of Obtaining Individual Patient Data2007
  15. An Investigation Into the Prognostic Significance of Necrosis and Hypoxia in High Grade and Invasive Bladder CancerThe Journal of Urology · 2007
  16. Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation SeriesClinical Cancer Research · 2007
  17. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1α pathway and prognosisJournal of Clinical Pathology · 2007
  18. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the Androgen receptor in prostate cancer but is not directly regulated by Androgens or hypoxiaThe Prostate · 2007
  19. The Unfolded Protein Response and Integrated Stress Response to AnoxiaClinical Cancer Research · 2007
  20. Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple CancersCancer Research · 2007
  21. Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic GradeJournal of Clinical Oncology · 2007
  22. The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia‐inducible factor (HIF)‐2α but not HIF‐1αThe Prostate · 2007
  23. BNIP3 as a Progression Marker in Primary Human Breast Cancer; Opposing Functions inIn situVersus Invasive CancerClinical Cancer Research · 2007
  24. Regulation of Hepatocyte Growth Factor Activator Inhibitor 2 by Hypoxia in Breast CancerClinical Cancer Research · 2007
  25. Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to HypoxiaStem Cells · 2006
  26. Role of hypoxia-inducible factor-1α as a cancer therapy targetEndocrine Related Cancer · 2006
  27. The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancerBritish Journal of Cancer · 2006
  28. Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late RelapseJournal of Clinical Oncology · 2006
  29. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumoursBritish Journal of Cancer · 2006
  30. Increased regulatory T-cell numbers distinguish high-risk breast cancer patients and those at risk of late relapseBreast Cancer Research · 2006
  31. Novel Thioredoxin Inhibitors Paradoxically Increase Hypoxia-Inducible Factor-α Expression but Decrease Functional Transcriptional Activity, DNA Binding, and DegradationClinical Cancer Research · 2006
  32. Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast CancerJNCI Journal of the National Cancer Institute · 2006
  33. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapyHealth Technology Assessment · 2006
  34. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancerEndocrine Related Cancer · 2006
  35. Circulating endothelial progenitor cells are inversely correlated with the median oxygen tension in the tumor tissue of patients with cervical cancerOncology Reports · 2006
  36. Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA bindingMolecular Cancer Therapeutics · 2006
  37. Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patientsInternational Journal of Cancer · 2006
  38. Up-Regulation of Endothelial Delta-like 4 Expression Correlates with Vessel Maturation in Bladder CancerClinical Cancer Research · 2006
  39. Lactate Dehydrogenase 5 Expression in Operable Colorectal Cancer: Strong Association With Survival and Activated Vascular Endothelial Growth Factor Pathway—A Report of the Tumour Angiogenesis Research GroupJournal of Clinical Oncology · 2006
  40. CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody bindingBritish Journal of Cancer · 2006
  41. Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast CancerClinical Cancer Research · 2006
  42. Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer PatientsJournal of Clinical Oncology · 2006
  43. The relation between hypoxia‐inducible factor (HIF)‐1α and HIF‐2α expression with anemia and outcome in surgically treated head and neck cancerCancer · 2006
  44. Molecular profiling of signalling proteins for effects induced by the anti-cancer compound GSAO with 400 antibodiesBMC Cancer · 2006
  45. Nuclear Factor-κB Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-κB DNA-BindingClinical Cancer Research · 2006
  46. Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinomaPROTEOMICS · 2006
  47. Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancerCancer Science · 2006
  48. Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructionsBritish Journal of Cancer · 2006
  49. Normoxic Stabilization of Hypoxia-Inducible Factor-1α by Modulation of the Labile Iron Pool in Differentiating U937 Macrophages: Effect of Natural Resistance–Associated Macrophage Protein 1Cancer Research · 2006
  50. Prognostic Value of an Activation State Marker for Epidermal Growth Factor Receptor in Tissue Microarrays of Head and Neck CancerCancer Research · 2006